B. Chanu

3.6k citations

31 papers · 327 indexed · h-index 10

Impact in

Endocrinology, Diabetes and Metabolism top 10%
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Treatment and Management
Cardiology and Cardiovascular Medicine
- Blood Pressure and Hypertension Studies
- Cardiovascular Function and Risk Factors

Papers in ⓘ

Surgery 15
- Lipoproteins and Cardiovascular Health 11
- Coronary Interventions and Diagnostics 2
- Cholesterol and Lipid Metabolism 2
Cardiology and Cardiovascular Medicine 9
- Lipid metabolism and disorders 6

Co-authors: Emmanuel Cosson (6 shared papers)Paul Valensi (3 shared papers)J Rouffy (15 shared papers)Minh Tuan Nguyen (2 shared papers)A. Avignon (1 shared paper)Ariane Sultan (1 shared paper)Giuseppe Mancia (1 shared paper)A. Facchini (1 shared paper)
Journals: Diabetes & Metabolism (2 papers)Clinica Chimica Acta (1 paper)Clinical Chemistry and Laboratory Medicine (CCLM) (1 paper)Journal of Hypertension (1 paper)European Journal of Human Genetics (1 paper)
Partner nations: France Italy Greece

In The Last Decade

B. Chanu

29 papers receiving 303 citations

Peers

Countries citing papers authored by B. Chanu

Since Specialization

Citations

This map shows the geographic impact of B. Chanu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Chanu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Chanu more than expected).

Fields of papers citing papers by B. Chanu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Chanu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Chanu. The network helps show where B. Chanu may publish in the future.

Co-authors

The 25 scholars most cited alongside B. Chanu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with B. Chanu Line = papers co-authored together B. Chanu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study Cardiovascular Diabetology ·Paul Valensi, A. Avignon, Ariane Sultan, B. Chanu, Minh Tuan Nguyen, Emmanuel Cosson	2016	56
2	Efficacy and tolerability profile of nebivolol vs atenolol in mild‐to‐moderate essential hypertension: Results of a double‐blind randomized multicentre trial Blood Pressure ·Guıdo Grassı, Fosca Quarti Trevano, A. Facchini, Torakis Toutouzas, B. Chanu, Giuseppe Mancia	2003	48
3	‘Pseudohypertriglyceridemia’ caused by hyperglycerolemia due to congenital enzyme deficiency Clinica Chimica Acta ·Yves Goussault, E Turpin, Dominique Néel, C Dreux, B. Chanu, R Bakir, J Rouffy	1982	32
4	Cardiovascular Risk Prediction Is Improved by Adding Asymptomatic Coronary Status to Routine Risk Assessment in Type 2 Diabetic Patients Diabetes Care ·Emmanuel Cosson, Minh Tuan Nguyen, B. Chanu, I. Banu, S. Chiheb, Cristina Balta, K. Takbou, Paul Valensi	2011	31
5	Nutritional AMD Treatment Phase I (NAT-1): Feasibility of Oral DHA Supplementation in Age-Related Macular Degeneration European Journal of Ophthalmology ·Giuseppe Querques, Pascale Benlian, B. Chanu, Céline Portal, G. Coscas, G. Soubrane, Eric H. Souied	2009	29
6	Comparative evaluation of the effects of ciprofibrate and fenofibrate on lipids, lipoproteins and apoproteins A and B Atherosclerosis ·J Rouffy, B. Chanu, R Bakir, F. Djian, J Goy-Loeper	1985	22
7	Determination of Plasma Protein-Bound Malondialdehyde by Derivative Spectrophotometry Clinical Chemistry and Laboratory Medicine (CCLM) ·Guillaume Lefèvre, Christine Bonneau, Sophie Rahma, B. Chanu, D. Brault, Rémy Couderc, Jacqueline Etienne	1996	12
8	Efficacy and safety of simvastatin (alone or in association with cholestyramine). A 1-year study in 66 patients with type II hyperlipoproteinaemia European Heart Journal ·Joseph Emmerich, Isabelle Aubert, B. Bauduceau, A. DACHET, B. Chanu, D. Erlich, Dany Gauthier, B Jacotot, J Rouffy	1990	12
9	The report of male gender and retinopathy status improves the current consensus guidelines for the screening of myocardial ischemia in asymptomatic type 2 diabetic patients Nutrition Metabolism and Cardiovascular Diseases ·Emmanuel Cosson, M.T. Nguyen, B. Chanu, Şevket Balta, K. Takbou, P. Valensi	2012	11
10	Autosomal dominant type IIa hypercholesterolemia: evaluation of the respective contributions of LDLR and APOB gene defects as well as a third major group of defects European Journal of Human Genetics ·Bruno Saint-Jore, Mathilde Varret, Christiane Dachet, Jean‐Pierre Rabès, Martine Devillers, Danielle Erlich, Patricia C. Blanchard, Michel Krempf, Denis Mathé, B. Chanu, B Jacotot, Michel Farnier, Catherine Bonaïti‐Pellié, Claudine Junien, Cathérine Boileau	2000	10
11	[Drug treatment of hyperlipoproteinemia]. PubMed ·B. Chanu	1987	9
12	Les désordres lipidiques des patients atteints d’affections causées par le VIH La Presse Médicale ·B. Chanu, P. Valensi	2005	7
13	Changes in lipid and lipoprotein levels and Achilles tendon diameters and indices in familial hypercholesterolaemic patients with tendinous xanthomatosis treated by diet and bezafibrate for 2 years Current Medical Research and Opinion ·J Rouffy, B. Chanu, R Bakir, J Goy-Loeper, F. Djian, Jean-Jacques Monsuez, Richard Gomberg, M Laval-Jeantet	1988	7
14	[Effects of simvastatin on plasma lipids, lipoproteins and apoproteins (A1 and B). 24 cases of major primary hypercholesterolemia]. PubMed ·Isabelle Aubert, Joseph Emmerich, Y Charpak, B. Chanu, C. Dachet, D Herlich, M Besseau, J Rouffy, B Jacotot	1988	7
15	Obesity, Metabolic Syndrome, Diabetes and Arterial Hypertension Immunology Endocrine & Metabolic Agents - Medicinal Chemistry ·Paul Valensi, B. Chanu, Emmanuel Cosson	2006	7
16	[Fenofibrate: hypolipaemic activity and safety in long-term treatment. Effects on HDL, LDL, VLDL and apoprotein B in short-term treatment (author's transl)]. PubMed ·J Rouffy, Sauvanet Jp, B. Chanu, R Bakir, J Goy-Loeper, C Saya, F Pinaroli	1980	4
17	[Hypertriglyceridemia: danger for the arteries]. PubMed ·B. Chanu	1999	4
18	NAT1: A Feasibility Study of Oral DHA Supplementation as a Nutritional AMD Treatment Investigative Ophthalmology & Visual Science ·E. Souied, Pascale Benlian, B. Chanu, W. Roquet, G. Coscas, G. Soubrane	2003	3
19	[Arthritis caused by a sea urchin spine. A new case]. PubMed ·Anthony Haddad, B. Chanu, I Aubert, J Rouffy	1989	3
20	Effects of Labetalol (400 mg/day) on Plasma Lipids, Lipoproteins and Apolipoproteins in Hypertensive Patients Journal of Hypertension ·J Rouffy, R Bakir, B. Chanu, F. Djian, J Goy-Loeper, Maxime Amar, D. Renon, Ph. Triaud	1985	2

About B. Chanu

B. Chanu is a scholar working on Surgery, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 31 papers that have together received 327 indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (11 papers), Lipid metabolism and disorders (6 papers), Cancer, Lipids, and Metabolism (5 papers), Cardiac Imaging and Diagnostics (4 papers), Metabolism and Genetic Disorders (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Coronary Interventions and Diagnostics (2 papers) and Cholesterol and Lipid Metabolism (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (111 citations), Cardiology and Cardiovascular Medicine (117 citations), Biochemistry (22 citations), Ophthalmology (31 citations) and Surgery (123 citations). B. Chanu has collaborated with scholars based in France, Italy and Greece. Frequent co-authors include Emmanuel Cosson, Paul Valensi, J Rouffy, Minh Tuan Nguyen, A. Avignon, Ariane Sultan, Giuseppe Mancia, A. Facchini, Fosca Quarti Trevano and Guıdo Grassı. Their work appears in journals such as Diabetes & Metabolism, Clinica Chimica Acta, Clinical Chemistry and Laboratory Medicine (CCLM), Journal of Hypertension and European Journal of Human Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact